
|Videos|October 30, 2013
Treating Patients with Early Stage Lung Cancer
Corey J. Langer, MD, discusses the treatment of patients with early stage lung cancer.
Advertisement
Corey J. Langer, MD, professor of medicine, hematology/oncology division, University of Pennsylvania, Abramson Cancer Center, discusses the treatment of patients with early stage lung cancer.
Clinical Pearls
- The major concerns in early stage disease include proper surgical resection and clean proximal nodes
- In patients with N1 or N2 involvement or stage 1 patients with tumors larger than 4 centimeters, standard postoperative care is adjuvant platinum-based chemotherapy for 4 cycles
- Patients with early stage lung cancer should undergo reflex testing because the information on marker status can be used later if the patient relapses
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
FDA Grants Tentative Approval to New Cabozantinib Capsule Formulation
2
FDA Clears Rituximab Biosimilar, Expanding Options for B-Cell Malignancies
3
In Squamous NSCLC, Cemiplimab Data Pulled the Room Away From Dual Checkpoint Blockade
4
Real-World Analysis Explores GLP-1 Use and Overall Survival
5










































